Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry (v3.5.4) was added to the study record history, and the previous revision (v3.5.3) was removed from the history listing.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA minor ClinicalTrials.gov page revision/version update changes the displayed “Revision: v3.5.x” label from v3.5.2 to v3.5.3 without altering the trial record’s substantive details.SummaryDifference0.1%

- Check49 days agoChange DetectedA new 'Study Status' entry was added to the history, and the record was upgraded to Revision v3.5.2, while the older Revision v3.5.0 was removed.SummaryDifference0.3%

- Check77 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed in the history. This looks like a system update with no changes to the study information visible on the page.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check113 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; no substantive changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.